NEW YORK, Oct. 12 - Phylos and Lawrence Livermore National Laboratory have said they would collaborate to develop new methods for protein production that could be applied to the development of new reagents and microarrays.
Under the terms of this deal, a team from Lawrence Livermore will work with Phylos to develop automated methods for the expression and production of cellular proteins.
Phylos has also gained access to Lawrence Livermore's full-length cDNA collection originally developed by the Integrated Molecular Analysis of Genomes and their Expression consortium. This collection can be used to generate information on the expression of recombinant proteins.
"Phylos will use these target proteins for our own internal efforts, and to service our collaborators using our high throughput, custom binding proteins for research reagent and microarray applications," Richard Wagner, senior vice president of research at Phylos, said in a statement released Thursday.
The findings from the collaboration are expected to have implications for the development of new diagnostic tools.
Phylos of Lexington, Mass, is focusing on how to produce large numbers of binding proteins to allow the assembly of high-throughput protein profiling platforms, such as microarrays.
Lawrence Livermore National Laboratory is managed by the University of California for the U.S. Department of Energy's National Nuclear Security Administration.